INNIO
22.9.2021 14:03:07 CEST | Business Wire | Press release
As part of its ongoing commitment to environmental stewardship, INNIO today announced the publication of its inaugural Sustainability Report, “Together for a Sustainable Future .” The theme of this report encompasses engagement of everyone -- with “together” being the key word indicating responsibility of all stakeholders in a journey to shape a sustainable future. The report highlights INNIO’s commitment to instituting a culture of transparency, providing progress updates and direction on INNIO’s global approach to sustainability covering its environmental, social, and governance (ESG) performance for 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210922005273/en/
In continuing its sustainability journey, INNIO’s leadership and its Sustainability Review Board (SRB) laid out the company’s ESG goals and strategy which included the development and publication of its first Sustainability Report. The report details how INNIO is working responsibly to deliver communities, industry, and the public with access to sustainable, reliable, and economical power while creating and maintaining an innovative, diverse, inclusive, pleasant and safe working environment for its employees.
Further, as INNIO’s Jenbacher and Waukesha products, services and digital solutions help unlock the transition to a carbon neutral future, INNIO’s Sustainability Report provides its stakeholders with indicators on commitment and progress to reducing greenhouse emissions and initiatives around responsible resource management.
In his opening note to the Sustainability Report, INNIO president and CEO, Carlos Lange, laid out key priorities and accomplishments:
Sustainability Goals
“As we continue to implement our enterprise strategy for profitable growth, we are also underlining our commitment to climate challenges and sustainable growth. INNIO’s Sustainability Goals are related to safety, energy and emissions, water, waste, building efficiency, circular economy, jobsite efficiency and sustainability of our products, services and solutions.”
Uninterrupted Access to Products and Services
“Along with our distributors and suppliers, INNIO is working to help ensure uninterrupted access to the products and services that our global customers rely on to support society during these difficult times. The recent COVID-19 global pandemic presented new challenges around the world, and INNIO was designated by many governments as an ‘essential’ enterprise since our products, parts and services support key infrastructure in the supply of natural gas and electrical energy. Customers use our products to provide primary and standby power & heat to homes; essential facilities such as hospitals, utilities, or district heating plants; and other businesses that must continue to operate.”
Technology Leadership: Hydrogen
“In Hamburg, INNIO Jenbacher and HanseWerk Natur recently collaborated to commission the world’s first large-scale gas engine in the 1 MW range capable of running on a variety of hydrogen-natural gas mixtures or on 100% green hydrogen. It’s also the world’s first natural gas engine conversion to hydrogen in the field. Again, INNIO technology is ahead of the game, demonstrating the future-proof nature of the installed base, this time by offering the ability to convert to carbon free, 100% hydrogen capabilities.”
Digitalization
“Through digitalization, we can constantly improve our products’ design and construction in our advanced factories, flawlessly execute our services, and move beyond reactive to predictive data solutions. At our manufacturing plants, we have embraced digitalization and are continuously refining our operations, accelerating innovation and improving our customers’ experience.”
The Sustainability Report publication follows recent sustainability activities that include INNIO’s recognition by EcoVadis with a Silver business sustainability rating , and INNIO’s joining the United Nations Global Compact . Each of these efforts underscores INNIO’s holistic and structured approach to incorporating sustainability across the company, considering the environment, employee development, health and safety, diversity and inclusion, as well as corporate responsibility.
INNIO’s Sustainability Report was developed in collaboration with external ESG advisors and subject matter experts as well as internal directors from diverse backgrounds.
About INNIO
INNIO is a leading provider of renewable gas, natural gas, and hydrogen-rich solutions and services for power generation and gas compression at or near the point of use. With our Jenbacher and Waukesha gas engines, INNIO helps to provide communities, industry and the public access to sustainable, reliable and economical power ranging from 200 kW to 10 MW. We also provide life-cycle support and digital solutions to the more than 53,000 delivered gas engines globally, through our service network in more than 100 countries. We deliver innovative technology driven by decarbonization, decentralization, and digitalization to help lead the way to a greener future. Headquartered in Jenbach, Austria, the business also has primary operations in Welland, Ontario, Canada, and Waukesha, Wisconsin, U.S. For more information, visit the company's website at www.innio.com . Follow INNIO on Twitter and LinkedIn .
At INNIO, we recognize that the growth of global economies and the industrialization that has accompanied this growth are directly impacting the future of our planet. We agree with the goals of the Paris Agreement—to stop global warming and lower temperatures to pre-industrial era levels by 2050. That’s why we took important steps in 2020 to address INNIO’s sustainability strategy, diving into the material issues we identified as the touchpoints to our customers and stakeholders. Our society faces unprecedented economic, environmental, social, and cultural challenges, and we are convinced that sustainability is the key to transforming these challenges into opportunities. Our sustainability strategy recognizes INNIO’s social and environmental responsibility. We must act now on this responsibility.
INNIO’s Sustainability Report is a non-financial disclosure presented for calendar year 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210922005273/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Acceleronix, IDEMIA Secure Transactions and Orange Announce Flexible, Single-SKU Manufacturing with Quantum-Safe IFPP4.11.2026 16:44:00 CET | Press release
One SKU. Every market. Connectivity decided at the end of production. Live at electronica 2026. Orange, one of the world’s leading telecom operators, has joined the global quantum-safe In-Factory Profile Provisioning (IFPP) program, jointly launched by Acceleronix and IDEMIA Secure Transactions at MWC Barcelona in February. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104070181/en/ Acceleronix, IDEMIA Secure Transactions and Orange announce flexible, single-SKU manufacturing with quantum-safe IFPP The program enables device makers to build a single product for every market and connect it to the Orange network before it leaves the factory. Acceleronix and IDEMIA Secure Transactions will demonstrate the solution live at electronica 2026, the international electronics trade fair, at Messe München, Hall C2, Stand 601, from 10 to 13 November. Most connected devices share the same weak spot: provisioning and testing on the pr
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 15:13:00 CET | Press release
If approved, BRUKINSA plus rituximab would be the first and only chemotherapy-free, BTK inhibitor-based regimen for adult patients with previously untreated mantle cell lymphomaApplication supported by Phase 3 MANGROVE data, showing a 43% reduction in the risk of progression or death versus bendamustine plus rituximabFull MANGROVE results to be presented during the Plenary Scientific Session at the 68th American Society of Hematology Annual Meeting BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of dis
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 15:00:00 CET | Press release
This framework agreement provides all entities subject to the French Public Procurement Code with simplified access to a support alternative enabling them to control their costs, preserve their freedom of technological choice and free themselves from vendor-imposed upgrade cycles Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMw
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 15:00:00 CET | Press release
New data in myeloproliferative neoplasms (MPNs) will include INCA033989, Incyte’s first-in-class, mutant calreticulin (mutCALR)-targeted monoclonal antibody, in first-line myelofibrosis (MF); and preclinical findings for Incyte’s next-generation mutCALR- and JAK2V617F-targeted compoundsUpdated results for INCA033989 in second-line MF and second-line essential thrombocythemia (ET) will build on previously presented datasetsLong-term Phase 1/2 data further characterize the potential of latarcibart (VGA039), an investigational Protein S-targeting antibody, as prophylaxis in adolescents and adults with von Willebrand disease (VWD)More than 30 abstracts will highlight progress across Incyte’s broader hematology portfolioIncyte will host an investor event and webcast on Saturday, December 12, 2026 from 7:30 – 9:00 p.m. CT (8:30 – 10:00 p.m. ET) Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstra
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 15:00:00 CET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
